ReviewFrontiers in medicine2026
AI-driven quality enhancement of medical datasets: a closed-loop framework of synthesis, annotation, quality control, and integration.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The performance ceiling of medical AI is largely determined by the quality of its training datasets, yet traditional manual collection and annotation face a triple bottleneck of high cost, embedded bias, and limited scalability. This review takes "quality enhancement" as its unifying axis, integrating the four pillars of AI-driven medical dataset quality enhancement-synthetic data generation, intelligent annotation, automated quality control, and integration pipelines-and proposes a four-pillar integration framework as its core contribution. The framework organizes the four pillars into a closed loop: synthesis and annotation are coupled through dual-track feedback (a quantity track that replenishes data and a strategy track that adjusts generation strategy), while annotation and quality control are coupled through bidirectional verification. Beyond this forward enhancement loop, the framework further employs a bias amplification chain (as a heuristic insight) and the privacy-utility tradeoff as two tension lines, and incorporates Metrics Reloaded, FAIR, ALCOA+, and YY/T 1833 as sub-layer evaluation dimensions in a complementary manner. The review shows that AI-based enhancement methods have approached real data in statistical fidelity and downstream utility for select modalities, tasks, and evaluation settings, but systematic gaps remain in privacy, fairness, and clinical validity; single-pillar optimization is hypothesized, on the basis of indirect segmental evidence, to be insufficient to improve end-to-end quality, and closed-loop synergy is proposed as a testable proposition rather than an established requirement; integration pipelines are already usable for single-disease, single-modality settings, whereas cross-institutional, cross-modal, and cross-disease generalization remains the principal barrier, with federated construction and foundation-model-driven approaches as promising directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.